Market Cap | ₹1,51,060Cr |
ROE | 14.64% |
P/E Ratio(TTM) | 65.50 |
EPS(TTM) | 86.87 |
P/B Ratio | 10.09 |
Dividend Yield | 0.53% |
Industry P/E | 33.86 |
Book Value | 563.87 |
Debt to Equity | 0.00 |
Face Value | 2 |
Parent Organisation | Divi's Laboratories Limited |
Managing Director | Dr. Murali Divi |
NSE Symbol | DIVISLAB |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Neuland Laboratories | NA (0.00%) | 101.64 | ||
Jubilant Pharmova | NA (0.00%) | 36.14 | ||
Acutaas Chemicals | NA (0.00%) | 58.44 | ||
Gujarat Themis Biosyn | NA (0.00%) | 97.44 |